The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014GSNOR Inhibition for Treatment of Parkinson’s Disease
Study Rationale:
Parkinson’s disease may be driven by inflammation and toxic, reactive products from oxygen metabolism. SAJE Pharma’s drugs target an enzyme called s... -
Rapid Response Innovation Awards, 2014Drug Rescue of PINK1: New Therapeutic Modality for Treating Parkinson’s Disease
Study Rationale:
Mitochondrial dysfunction has long been linked to Parkinson’s disease. We are investigating a class of drugs that increase the activity of an important mitochondrial quality... -
Rapid Response Innovation Awards, 2014Functional Characterization of HIP1R in Parkinson’s Disease
Study Rationale:
Intracellular vesicle trafficking is an important mechanism for delivering proteins to their proper location where they can function within cells. Various genes... -
Target Validation, 2014Transferrin Receptor 2 as a Target to Halt Iron Overload in Parkinson's Disease
Objective/Rationale:
Iron is an element naturally present in the brain and is required for its proper function. Iron levels, however, must be tightly controlled because excessive amounts... -
Research Grant, 2014Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease
Study Rationale:
The loss of the antioxidant glutathione in the brain of individuals with Parkinson’s disease (PD) occurs years before the onset of motor symptoms. Glutathione has... -
Target Validation, 2014Inhibition of a Dopamine Receptor in Lymphocytes as a Treatment for Parkinson's Disease
Objective/Rationale:
Emerging evidence has shown that lymphocytes, a kind of immune system cells, play a fundamental role in the development and progression of Parkinson's diseases. Our...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.